Educational guide
Peptide for Determination of PDL1 Expression in Tumors | LifeTein Peptide Blog
Blocking the interaction between Programmed Death Ligand 1 (PD-L1) and its receptor, PD-1, is an effective method of treating many types of cancers. Identifying the PD-L1 binding peptide and mock peptide: Select from a library of peptides for stability and hig
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Blocking the interaction between Programmed Death Ligand 1 (PD-L1) and its receptor, PD-1, is an effective method of treating many types of cancers.
Identifying the PD-L1 binding peptide and mock peptide: Select from a library of peptides for stability and high affinity.
Fluorescent target peptide-Cy5 as Marker for Flow Cytometry.
Detection of PD-L1 in circulating tumor cells using the Cy5 or Cy7 (infrared) labeled peptides.
Biotinylated peptides to detect PD-L1 in sample tissues. The streptavidin-HRP are used.
Fluorescent Cy5-labeled peptides detects PD-L1 in sample tissues.
By utilizing a peptide-based approach, it is possible to detect all levels of PD-L1 with high sensitivity and specificity.
Reference:
https://www.nature.com/articles/s41598-017-10946-2